vTv Therapeutics Ownership | Who Owns vTv Therapeutics?
vTv Therapeutics Ownership Summary
vTv Therapeutics is owned by 1.65% institutional investors, 38.98% insiders, and 59.37% retail investors. Samsara biocapital is the largest institutional shareholder, holding 3.54% of VTVT shares. Fidelity Select Biotechnology is the top mutual fund, with 6.61% of its assets in vTv Therapeutics shares.
VTVT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | vTv Therapeutics | 1.65% | 38.98% | 59.37% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Samsara biocapital | 298.50K | 3.54% | $11.84M |
| Fmr | 260.39K | 3.09% | $10.33M |
| Millennium management | 206.29K | 2.45% | $8.18M |
| Siren | 163.00K | 1.94% | $6.46M |
| Baker bros. advisors lp | 148.31K | 1.76% | $5.88M |
| Vanguard group | 83.40K | 1.04% | $3.34M |
| Geode capital management | 32.89K | 0.39% | $1.31M |
| Northern trust | 18.05K | 0.21% | $715.94K |
| Vanguard fiduciary trust | 16.13K | 0.19% | $639.56K |
| 683 capital management | 16.00K | 0.19% | $634.56K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Samsara biocapital | 298.50K | 1.15% | $11.84M |
| Connective capital management | 9.71K | 0.21% | $226.78K |
| Siren | 163.00K | 0.18% | $6.46M |
| Baker bros. advisors lp | 148.31K | 0.03% | $5.88M |
| 683 capital management | 16.00K | 0.03% | $634.56K |
| Millennium management | 206.29K | 0.00% | $8.18M |
| Brevan howard capital management lp | 7.53K | 0.00% | $298.68K |
| Strengthening families & communities | 173.00 | 0.00% | $6.86K |
| Pathstone | 6.07K | 0.00% | $240.87K |
| Marshall wace, llp | 13.39K | 0.00% | $531.01K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Millennium management | 206.29K | 0.00% | 206.29K |
| Vanguard group | 83.40K | - | 36.41K |
| Vanguard fiduciary trust | 16.13K | 0.00% | 16.13K |
| Marshall wace, llp | 13.39K | 0.00% | 13.39K |
| State street | 10.67K | - | 10.67K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 260.39K | 0.00% | -8.46K |
| 683 capital management | 16.00K | 0.03% | -2.27K |
| Tower research capital llc (trc) | - | - | -1.27K |
| Citigroup | - | - | -244.00 |
| Jpmorgan chase | - | - | -3.00 |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vanguard fiduciary trust | 16.13K | 0.00% | 16.13K | $639.56K |
| Marshall wace, llp | 13.39K | 0.00% | 13.39K | $531.01K |
| State street | 10.67K | - | 10.67K | $423.01K |
| Brevan howard capital management lp | 7.53K | 0.00% | 7.53K | $298.68K |
| Qube research | 5.62K | 0.00% | 5.62K | $222.81K |
Sold Out
| Holder | Change |
|---|---|
| Raymond james financial | -1.00 |
| Jpmorgan chase | -3.00 |
| Citigroup | -244.00 |
| Tower research capital llc (trc) | -1.27K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 13 | -50.00% | 138,737 | -89.19% | 1 | 0.65% | 7 | -53.33% | - | -100.00% |
| Dec 31, 2025 | 16 | -30.43% | 300,228 | -69.62% | 3 | 1.66% | 9 | -18.18% | 1 | -66.67% |
| Sep 30, 2025 | 21 | - | 978,552 | 66.66% | 14 | 18.70% | 11 | 22.22% | 3 | - |
| Jun 30, 2025 | 21 | 5.00% | 587,123 | 2.70% | 8 | 11.82% | 8 | 14.29% | 4 | -20.00% |
| Mar 31, 2025 | 20 | 17.65% | 571,712 | 3.68% | 8 | 9.51% | 7 | 16.67% | 5 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Select Biotechnology | 260.39K | 6.61% | - |
| Vanguard Total Stock Mkt Idx Inv | 74.35K | 1.89% | - |
| Vanguard US Total Market Shares ETF | 33.45K | 1.28% | -211.00 |
| Vanguard Institutional Extnd Mkt Idx Tr | 31.52K | 0.80% | - |
| Fidelity Extended Market Index | 15.12K | 0.38% | 439.00 |
| Extended Equity Market Fund E | 5.82K | 0.15% | 5.82K |
| Extended Equity Market Fund B | 5.82K | 0.15% | 5.82K |
| Blackrock Extended Mkt Fund CF | 5.82K | 0.15% | - |
| iShares Micro-Cap ETF | 5.28K | 0.13% | - |
| BlackRock Extended Equity Market Fund K | 4.95K | 0.13% | -36.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 15, 2024 | SEKHRI PAUL J | Pres, CEO and Exec Chairperson | Buy | $22.53K |
| Nov 15, 2024 | SEKHRI PAUL J | Pres, CEO and Exec Chairperson | Buy | $30.01K |
| Nov 18, 2024 | SEKHRI PAUL J | Pres, CEO and Exec Chairperson | Buy | $31.27K |
| Nov 29, 2022 | FRY JOHN A | - | Buy | $33.77K |
| Nov 28, 2022 | FRY JOHN A | - | Buy | $16.97K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | 3 | - |
VTVT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools